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ABSTRACT
Objective: To assess the risk of perinatal
complications in overweight and obese women with
and without type 1 diabetes (T1DM).
Design: Prospective population-based cohort study.
Setting: This study was based on data from the
Swedish Medical Birth Registry from 1998 to 2007.
Participants: 3457 T1DM and 764498 non-diabetic
pregnancies were included. T1DM was identiﬁed based
on ICD code O24.0. Mothers were categorised according
to pre-pregnancy body mass index (BMI: weight in
kilograms per height in square metres) as normal weight
(BMI 18.5e24.9), overweight (BMI 25e29.9) or obese
(BMI $30). Only women with singleton pregnancies and
with data on BMI were included.
Primary/secondary outcomes: The primary
outcome was large for gestational age (LGA: birth
weight >90th percentile) infants. Secondary outcomes
were major malformations, pre-eclampsia (PE),
preterm delivery, perinatal mortality, delivery by
Caesarean section and neonatal overweight. Logistic
regression analysis was performed with normal weight
non-diabetic women as the reference category and
also within the diabetic cohort with normal weight
type 1 diabetic women as the reference. The ORs were
adjusted for ethnicity, maternal age, height, parity,
smoking and chronic hypertension.
Results: 35% of women with T1DM were overweight
and 18% were obese, as compared with 26% and
11%, respectively, in non-diabetic pregnancies. The
incidences of adverse outcome increased with greater
BMI category. As compared with non-diabetic normal
weight women, the adjusted OR for obese T1DM for
LGA was 13.26 (95% CI 11.27 to 15.59), major
malformations 4.11 (95% CI 2.99 to 5.65) and PE
14.19 (95% CI 11.50 to 17.50). T1DM was
a signiﬁcant effect modiﬁer of the association between
BMI and LGA, major malformations and PE (p<0.001).
Conclusion: High pre-pregnancy BMI is an important
risk factor for adverse outcome in type 1 diabetic
pregnancies. The combined effect of both T1DM and
overweight or obesity constitutes the greatest risk. It
seems prudent to strive towards normal pre-
pregnancy BMI in women with T1DM.
INTRODUCTION
Body mass index (BMI) has increased among
fertile women in many countries, including
Sweden.
1 Maternal overweight and obesity
are well-known risk factors for adverse preg-
nancy outcome. High pre-pregnancy BMI has
been associated with increased risk for still-
birth, fetal malformations, large for date
neonates, neonatal and infant death, preg-
nancy-induced hypertension and pre-
eclampsia (PE), maternal diabetes, delivery
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ARTICLE SUMMARY
Article focus
- To assess the risk of obstetric and perinatal
complications in overweight and obese women
with and without type 1 diabetes (T1DM).
Key messages
- High pre-pregnancy body mass index (BMI) is an
important risk factor for adverse outcome in type
1 diabetic pregnancies.
- The combined effect of both T1DM and over-
weight or obesity constitutes the greatest risk.
- T1DM is a signiﬁcant effect modiﬁer of the asso-
ciation between BMI and large for gestational
age, major malformations and pre-eclampsia
(p<0.001).
Strengths and limitations of this study
- The present study is to our knowledge, the ﬁrst
to present risk estimates of several obstetric and
perinatal complications in women with T1DM,
stratiﬁed by BMI category and compared with
a non-diabetic reference population. The popula-
tion-based study design, including a very large
cohort of T1DM pregnancies, offers a unique
possibility to provide solid data on risks
associated with high BMI, including compara-
tively rare outcomes such as perinatal mortality.
A potential limitation is that the study design did
not allow assessment of the impact of maternal
glycaemic control on the association between
exposure and outcome.
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Open Access Researchby Caesarean section as well as increased numbers of
days spent in hospital for both mother and infant.
2e11
The pathophysiological mechanism behind the
increased risk of adverse pregnancy outcome in obese
women is not fully understood. Increased insulin resis-
tance and a state of inﬂammation associated with
obesity
12 are likely important contributing factors.
Given the links between overweight, insulin resistance
and adverse pregnancy outcome, any additional preg-
nancy risks in overweight women with diabetes are
important to disclose, especially since overweight and
obesity are more prevalent among diabetic women than
in the general obstetric population.
13 Increased risks of
neonatal and maternal morbidity have been reported
in overweight and obese women with gestational
diabetes.
14e16 In contrast, data are very limited regarding
the impact of high maternal BMI on the risk of
adverse pregnancy outcome in women with type 1 dia-
betes (T1DM). An interaction between maternal diabetes,
including both pregestational and gestational diabetes,
and obesity has been suggested to increase the risk of
malformations in the offspring.
17 However, the majority
of women in that study had gestational diabetes and no
separate analysis was performed in women with T1DM.
The aim of the present study was to analyse the asso-
ciation between maternal overweight and obesity and
the risk of fetal and obstetric complications in type 1
diabetic pregnancies, with special reference to the high
and increasing incidence of large for gestational age
infants.
13 This study includes a large national cohort of
more than 3000 type 1 diabetic pregnancies, and the risk
of adverse outcome in relation to maternal BMI was also
compared with non-diabetic pregnancies. Our hypoth-
esis was that maternal overweight/obesity and maternal
T1DM have independent impact on the risk of adverse
outcome and that the combination of the two constitutes
the greatest risk.
RESEARCH DESIGN, MATERIALS AND METHODS
This population-based cohort study was based on data
from the Swedish Medical Birth Registry (MBR). The
MBR prospectively collects information on maternal
medical history, obstetric and neonatal diagnoses and
covers more than 99% of all pregnancies in Sweden.
Until 2008, the MBR did only collect data on pregnan-
cies from 28
0/7 weeks of gestation and did not register
data on earlier fetal losses or induced abortions. The
quality of data in the registry is continuously evaluated by
the National Board of Health and the conclusion of the
latest extensive validation in 2002 was that quality of data
is high.
18 Maternal and neonatal diagnoses were classi-
ﬁed according to ICD-10, introduced in Sweden in 1997.
ICD-9 codes were also included to ensure that no
patients would be missed. All diagnoses were made by
a physician before hospital discharge and copies of the
records were forwarded to the MBR. Maternal charac-
teristics included in the present study were mother’s
age, parity, pre-pregnancy weight, height, chronic
hypertension, smoking habits and whether the mother
was born in one of the Nordic countries (Sweden,
Finland, Denmark, Norway or Iceland) or elsewhere.
Chronic hypertensive disease ICD-10 I10 or O10.0) was
deﬁned as blood pressure above 140/90 mm Hg diag-
nosed before pregnancy or before 20 weeks of gestation.
Maternal height and pre-pregnancy weight were
recorded by recall, and BMI was calculated as weight in
kilograms divided by the square of the height in metres.
Exposure in women with and without T1DM was deﬁned
as overweight (BMI $25e29.9 kg/m
2) or obese (BMI
$30 kg/m
2), and pregnancy outcomes were compared
with that of normal weight women (BMI 18.5e24.9 kg/
m
2). Women with BMI< 18.5 kg/m
2 (under weight) and
records with missing data on BMI were excluded as well
as records with extreme values on maternal age (<13 or
>54 years), maternal weight (<40 or >200 kg) or
maternal height (<120 or >200 cm). We applied the
same limits for data acceptance of birth weight and birth
length as in the National Perinatal Quality Registry in
Sweden: that is, records with birth weight <200 or
>9998 g or birth length <15 or >65 cm, were excluded.
Study cohort
Infants from singleton pregnancies and born to mothers
with T1DM in Sweden between 1998 and 2007 were
included, in total n¼3457. Type 1 diabetic pregnancies
were identiﬁed based on ICD-10 code O240 and ICD-9
code 250 for pregestational diabetes.
Non-diabetic cohort
The reference group (n¼764498) included all singleton
pregnancies to mothers without a diagnosis of diabetes
(based on ICD-10 and -9 codes for T1DM (O240,
25031/33), type 2 diabetes (O241) and all codes
starting with E11 and E 177-119, 25030/32 or gesta-
tional diabetes codes (O244 A, B, X, 648.8)) and born in
the same time period as the study cohort. Percentiles for
birth weight were based on all live born, singleton
infants, without major malformations to mothers
without a diagnosis of diabetes. Birthweight percentiles
were adjusted for sex and gestational age.
Primary outcome
Fetal macrosomia, that is, giving birth to a large for
gestational age (LGA) infant, was the primary outcome
of this study. LGA was deﬁned as a birth weight >90th
percentile for sex and gestational age.
Secondary outcomes
Secondary outcomes were major malformations, PE,
preterm delivery, perinatal mortality, delivery by
Caesarean section (emergency and elective) and
neonatal overweight. Major malformations were prede-
ﬁned in the MBR as fatal or potentially life-threatening
malformations or if the malformation would likely lead
to a serious handicap or major cosmetic defect if not
surgically corrected. PE was deﬁned as a blood pressure
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proteinuria (at least 0.3 g/day or >1+ on a urine
dipstick, ICD-10 codes: O14.0, O14.1 and O15/ICD-9
codes: 642.4, 642.5 and 642.6). Preterm birth was
deﬁned as delivery before 37 gestational weeks. Perinatal
mortality was deﬁned as intrauterine death after
28
0/7 weeks of gestation or death during the ﬁrst week of
postnatal life. Neonatal overweight was deﬁned as birth
weight and ponderal index (PI, birth weight in grams
per length in cubic centimetres) above the 90th
percentile for sex and gestational age.
This study was approved by the Regional Ethical
Review Board in Uppsala, Sweden.
Statistical methods
Comparison between groups were made using Kruskale
Wallis test for continuous data and c
2 test and c
2 test for
trend for binary and categorical data as appropriate.
Unconditional logistic regression was used to explore
associations between maternal BMI categories and
adverse outcomes with normal weight (BMI 18.5e
24.9 kg/m
2) women as the reference category as follows:
the ORs of adverse outcomes in relation to BMI category
were estimated in women with T1DM with (1) normal
weight women with T1DM as reference category and (2)
normal weight non-diabetic women as reference cate-
gory. Crude and adjusted ORs were calculated. The
following variables were included in the ﬁnal model for
LGA as possible confounders/covariates: Nordic origin
(yes/no), maternal age, height, parity, smoking and
chronic hypertension. The ﬁnal regression models for
the secondary outcomes included covariates signiﬁcantly
associated with the outcomes in univariate analysis.
Missing indicator variables were used for maternal age
and height. The likelyhood ratio test was used to explore
potential interaction between BMI categories and T1DM
for the risk of the adverse outcomes. A p value <0.05 was
considered signiﬁcant. All statistical analyses were
performed using STATA 10.1 SE.
RESULTS
Between 1998 and 2007, there were 947096 deliveries in
Sweden, including 4208 (0.4%) deliveries to mothers
with T1DM. Of all pregnancies, we excluded 441 records
(0.05%) with extreme values on maternal age, maternal
weight or height. No records were excluded due to
extreme values on birth weight, but 3402 records were
missing for this variable. We excluded 90 records
(0.01%) due to extreme values on birth length and
14544 were missing for birth length. In women with
T1DM, 652 records (15%) were excluded due to missing
data on maternal BMI or BMI <18.5 and 116 (2.8%) due
to multiple pregnancies. Seventeen records were iden-
tiﬁed as both missing for BMI and with multiple preg-
nancies, thus giving a ﬁnal study cohort of 3457 infants
(1758 male infants, 51%) born to mothers with T1DM.
The reference population included 764498 singleton
pregnancies to mothers without a diagnosis of diabetes,
excluding 28018 records from multiple pregnancies and
147835 records with missing data on maternal BMI or
BMI <18.5.
Reference percentiles for birth weight, birth length
and PI were formed using records from all non-diabetic
pregnancies and excluding stillborn infants (0.31%),
infants with major malformations (1.84%) and multiple
pregnancies (3.01%).
Maternal and infant characteristics
Mothers with T1DM had a signiﬁcantly higher median
pre-pregnancy BMI (25.1 kg/m
2) compared with the
non-diabetic group (23.6 kg/m
2,p <0.001). In the type 1
diabetic cohort, 35% (n¼1195) of women were over-
weight and 18% (n¼618) were obese as compared with
26% (n¼200600) and 11% (n¼82331), respectively, in
the non-diabetic population. Women with T1DM were
also more often of Nordic origin and had a higher
prevalence of chronic hypertension and smoking during
the ﬁrst trimester compared with women without dia-
betes (p value for all comparisons <0.01). Infants to
mothers with T1DM were born at a signiﬁcantly lower
median gestational age, and preterm birth was four
times as common compared with non-diabetic offspring
(p value for all comparisons <0.001). The median birth
weight was signiﬁcantly higher in infants delivered by
mothers with T1DM than in the reference group, table 1.
Adverse outcomes in relation to BMI category
Overall, the incidence of all adverse outcomes was
signiﬁcantly higher in women with T1DM, irrespective of
BMI category. The incidence of the primary outcome
LGA was highest in obese type 1 diabetic women;
however, the differences between BMI categories did not
reach statistical signiﬁcance within the diabetes cohort.
The incidence of all secondary outcomes was highest in
obese women with T1DM, except for perinatal mortality
in type 1 diabetic pregnancies with the highest recorded
frequency in overweight women. Within the non-dia-
betic pregnancies, the incidence of all outcomes
increased signiﬁcantly with greater BMI category (c
2 for
trends for all outcomes p<0.001) (table 2).
There was a similar pattern of increasing OR for
adverse outcome with greater BMI category in women
with and without T1DM. Inclusion of maternal covariates
in the regression models did not signiﬁcantly change
these estimates. Relative to a normal weight non-diabetic
woman, the adjusted OR for the risk of having a LGA
infant in overweight or obese women with T1DM was
approximately 13 as compared with approximately 2 in
overweight and obese non-diabetic women, table 3.I n
relation to a normal weight woman without diabetes,
obesity in women with T1DM was associated with an
adjusted OR for major malformation of 4.11 (95% CI
2.99 to 5.65) as compared with 1.15 (95% CI 1.09 to
1.22) in non-diabetic women with obesity. Compared
with a normal weight non-diabetic woman, the adjusted
ORs for PE in a woman with T1DM of normal weight was
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overweight 9.91 (95% CI 8.61 to 11.40) and in obese type
1 diabetic women, the adjusted OR was 14.19 (95% CI
11.50 to 17.50). The corresponding estimates for a non-
diabetic woman with overweight or obesity were 1.74
(95% CI 1.69 to 1.80) and 3.37 (95% CI 3.25 to 3.49),
respectively. The OR for Caesarean section increased
with BMI category, both in women with and without
T1DM, table 3.
Table 4 shows the OR for adverse outcome in women
with T1DM by BMI category with normal weight women
with T1DM as the reference category. In obese type 1
Table 1 Maternal and infant characteristics, type 1 diabetes and non-diabetic reference population
Type 1 diabetes,
N[3457
Non-diabetic population,
N[764498 p Value*
Maternal characteristics
Nordic, n (%) 3194 (92) 643608 (84) <0.001
Swedish origin, n (%) 3151 (91) 628534 (82) <0.001
Maternal age, years (median, IQR) 30 (27e34) 30 (27e33) <0.001
Smoking ﬁrst trimester, n (%) 384 (11) 72766 (10) 0.001
Primipara, n (%) 1559 (45) 337199 (44) 0.242
BMI, kg/m
2 (median, IQR) 25.1 (23.0e28.4) 23.6 (21.6e26.4) <0.001
Overweight (BMI $25e29.9), n (%) 1195 (35) 200600 (26) <0.001
Obese (BMI $30), n (%) 618 (18) 82331 (11) <0.001
Height, cm (median, IQR) 167 (162e170) 167 (162e170) 0.250
Chronic hypertension, n (%) 92 (2.7) 2472 (0.32) <0.001
Infant characteristics
Male, n (%) 1758 (51) 393324 (51) 0.485
Gestational age, weeks (median, IQR) 38 (37e39) 40 (39e41) <0.001
Preterm delivery, n (%) 741 (21) 35878 (4.7) <0.001
Birth weight, g (median, IQR) 3805 (3350e4265) 3575 (3240e3915) <0.001
Birth length, cm (median, IQR) 51 (49e52) 51 (49e52) 0.576
LGA, BW >90 percentile, n (%) 1694 (49) 81142 (11) <0.001
AGA, BW 10e90 percentile, n (%) 1661 (48) 614784 (80) <0.001
SGA, BW <10 percentile, n (%) 109 (3.2) 76214 (10) <0.001
*c
2 test, ranksum test.
AGA, appropriate for gestational age; BMI, body mass index; BW, birth weight; LGA, large for gestational age; SGA, small for gestational age.
Table 2 Perinatal outcomes for pregnant women with or without type 1 diabetes and stratiﬁed on pre-pregnancy BMI
BMI 18.5e24.9 BMI 25e29.9 BMI ‡30 p Value*
LGA infant
Type 1 diabetes 778 (47) 603 (50) 313 (51) 0.170
Non-diabetic 39265 (8.2) 26828 (13) 15049 (18) <0.001
Major malformations
Type 1 diabetes 65 (4.0) 44 (3.7) 41 (6.6) 0.008
Non-diabetic 8186 (1.7) 3736 (1.9) 1610 (2.0) <0.001
Pre-eclampsia
Type 1 diabetes 222 (14) 185 (15) 114 (18) 0.012
Non-diabetic 9872 (2.1) 6529 (3.3) 4810 (5.8) <0.001
Preterm delivery
Type 1 diabetes 322 (20) 275 (23) 144 (23) 0.041
Non-diabetic 21714 (4.5) 9464 (4.7) 4700 (5.7) <0.001
Perinatal mortality
Type 1 diabetes 14 (0.85) 15 (1.3) 6 (0.97) 0.566
Non-diabetic 1554 (0.32) 948 (0.47) 593 (0.72) <0.001
Caesarean section
Type 1 diabetes 748 (46) 639 (53) 362 (59) <0.001
Non-diabetic 64131 (13) 34081 (17) 18166 (22) <0.001
Neonatal overweight
Type 1 diabetes 351 (21) 288 (24) 166 (27) 0.016
Non-diabetic 15359 (3) 10430 (5) 6466 (8) <0.001
Data are presented as numbers (percentages).
*c
2 test, KruskaleWallis test, c
2 test for trends.
BMI, body mass index; LGA, large for gestational age.
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tions (1.77 (95% CI 1.18 to 2.65)) and PE (1.74 (95% CI
1.35 to 2.25)) were signiﬁcantly increased compared
with normal weight type 1 diabetic women. The OR of
Caesarean section was signiﬁcantly increased in both
overweight and obese type 1 diabetic women, table 4.
The OR for LGA did not differ signiﬁcantly between the
different BMI categories. However, the adjusted OR for
delivering a disproportionate LGA infant with neonatal
overweight (PI >90th percentile) was signiﬁcantly
Table 3 Crude and adjusted* ORs (95% CI) for adverse perinatal outcomes in pregnant women with and without T1DM and
stratiﬁed on pre-pregnancy BMI
BMI 18.5e24.9 BMI 25e29.9 BMI ‡30 Interaction p-valuey
LGA infant
T1DM
Crude 10.16 (9.10 to 11.36) 12.40 (11.22 to 13.70) 12.29 (10.50 to 14.40) <0.001
Adjusted 10.72 (9.56 to 12.01) 13.55 (12.23 to 15.02) 13.26 (11.27 to 15.59) <0.001
Non-diabetic
Crude 1.0 1.74 (1.71 to 1.77) 2.52 (2.47 to 2.57) <0.001
Adjusted 1.0 1.76 (1.73 to 1.79) 2.60 (2.55 to 2.66) <0.001
Major malformations
T1DM
Crude 2.28 (1.71 to 3.04) 2.34 (1.81 to 3.02) 4.11 (2.99 to 5.65) 0.03
Adjusted 2.28 (1.71 to 3.04) 2.34 (1.81 to 3.03) 4.11 (2.99 to 5.65) 0.03
Non-diabetic
Crude 1.0 1.10 (1.06 to 1.14) 1.15 (1.09 to 1.22) 0.03
Adjusted 1.0 1.10 (1.06 to 1.14) 1.15 (1.09 to 1.22) 0.03
Pre-eclampsia
T1DM
Crude 7.12 (6.02 to 8.42) 9.30 (8.11 to 10.67) 11.23 (9.15 to 13.77) <0.001
Adjusted 7.17 (6.04 to 8.50) 9.91 (8.61 to 11.40) 14.19 (11.50 to 17.50) <0.001
Non-diabetic
Crude 1.0 1.61 (1.56 to 1.66) 2.96 (2.86 to 3.07) <0.001
Adjusted 1.0 1.74 (1.69 to 1.80) 3.37 (3.25 to 3.49) <0.001
Preterm delivery
T1DM
Crude 4.86 (4.22 to 5.60) 6.23 (5.53 to 7.02) 6.39 (5.30 to 7.71) 0.16
Adjusted 4.72 (4.09 to 5.44) 5.98 (5.31 to 6.74) 5.97 (4.94 to 7.21) 0.15
Non-diabetic
Crude 1.0 1.05 (1.02 to 1.07) 1.28 (1.24 to 1.32) 0.16
Adjusted 1.0 1.04 (1.02 to 1.07) 1.26 (1.22 to 1.30) 0.15
Perinatal mortality
T1DM
Crude 2.55 (1.36 to 4.76) 3.93 (2.49 to 6.19) 3.14 (1.40 to 7.04) 0.29
Adjusted 2.46 (1.32 to 4.60) 3.72 (2.36 to 5.89) 2.86 (1.27 to 6.44) 0.31
Non-diabetic
Crude 1.0 1.47 (1.35 to 1.59) 2.24 (2.04 to 2.46) 0.29
Adjusted 1.0 1.46 (1.35 to 1.59) 2.22 (2.03 to 2.44) 0.31
Caesarean section
T1DM
Crude 5.59 (5.00 to 6.25) 7.09 (6.42 to 7.83) 9.44 (8.04 to 11.08) 0.42
Adjusted 5.69 (5.09 to 6.37) 7.12 (6.44 to 7.88) 9.35 (7.95 to 11.00) 0.36
Non-diabetic
Crude 1.0 1.33 (1.31 to 1.35) 1.84 (1.81 to 1.88) 0.42
Adjusted 1.0 1.34 (1.32 to 1.36) 1.87 (1.83 to 1.90) 0.36
Neonatal overweight
T1DM
Crude 8.46 (7.39 to 9.70) 9.93 (8.83 to 11.17) 11.71 (9.79 to 14.00) <0.001
Adjusted 8.40 (7.32 to 9.64) 9.86 (8.76 to 11.11) 11.29 (9.42 to 13.53) <0.001
Non-diabetic
Crude 1.0 1.66 (1.62 to 1.71) 2.59 (2.51 to 2.67) <0.001
Adjusted 1.0 1.65 (1.61 to 1.69) 2.55 (2.48 to 2.63) <0.001
Reference group: non-diabetic women with normal pre-pregnancy BMI.
*Adjusted for ethnicity, maternal age, height, parity, smoking ﬁrst trimester and chronic hypertension.
yInteraction between BMI category and T1DM.
BMI, body mass index; LGA, large for gestational age; T1DM, type 1 diabetes.
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1.09 to 1.69).
DISCUSSION
This study shows that high maternal pre-pregnancy BMI
is a very important risk factor for adverse pregnancy
outcome in women with and without T1DM. High
maternal BMI and T1DM are independent risk factors
for maternal and perinatal complications. However,
T1DM remains a stronger risk factor for adverse
outcome than obesity. The risk of adverse outcome in
women with concomitant T1DM and obesity exceeds that
of either condition alone, indicating synergism between
the two exposures. Obesity in T1DM is associated with
signiﬁcantly increased risk of PE, major malformations,
neonatal overweight and Caesarean section as compared
with type 1 diabetic women with normal BMI.
The prevalence of overweight and obesity in pregnant
women is increasing in Sweden and worldwide,
1 12 and
the harmful effects of high maternal BMI on pregnancy
outcome are well established in the general obstetric
population.
2e11 On the other hand, data on the potential
association between high maternal BMI and adverse
pregnancy outcome in women with T1DM is scarce.
17 19 20
In a cohort of 46 women with T1DM and nephropathy,
maternal overweight was identiﬁed as an important risk
factor for poor pregnancy outcome.
19 In mixed popula-
tions of women with pregestational diabetes, maternal
obesity has been associated with pregnancy complica-
tions
20 and increased risk of birth defects.
17 These two
studies however do not separate women with diabetes
type 1 from those with diabetes type 2 and do not include
any comparable data from a non-diabetic reference
population.
The present study is to our knowledge the ﬁrst to
present risk estimates of obstetric and perinatal compli-
cations in a large cohort of women with exclusively
T1DM, stratiﬁed by BMI category and compared with
a non-diabetic reference population. The large sample
size enabled risk estimation of rare outcomes such as
perinatal mortality and major malformations in relation
to subgroups of maternal BMI. The population-based
study design provides unanimous risk estimates for
overweight and obese women with and without T1DM.
The vast majority of our study population is of Nordic
origin and 91% were Swedish. The study population is
also homogenous with respect to medical care in preg-
nancy. In Sweden, healthcare is free of charge as well as
insulin, test strips for home monitoring of glucose and
equipment for insulin administration. The care of
pregnant women with T1DM is uniform over the whole
country and pregnancy outcome does not differ with
geographical area.
13
Some limitations with the present study should be
noted. BMI was calculated from recalled data on pre-
pregnancy weight and height. Women tend to underes-
timate their weight, and it has been demonstrated that
this bias increases directly with the degree of over-
weight.
21 A potential misclassiﬁcation of women to lower
BMI categories would lead to an underestimation of our
Table 4 Crude and adjusted* ORs; 96% CI for adverse perinatal outcome in pregnant women with T1DM and stratiﬁed on BMI
T1DM
BMI 18.5e24.9 BMI 25e29.9 BMI ‡30
LGA infant
Crude 1.0 1.13 (0.98 to 1.32) 1.14 (0.95 to 1.37)
Adjusted 1.0 1.18 (1.01 to 1.38) 1.21 (1.00 to 1.47)
Major malformations
Crude 1.0 0.93 (0.63 to 1.37) 1.73 (1.15 to 2.58)
Adjusted 1.0 0.92 (0.62 to 1.36) 1.77 (1.18 to 2.65)
Pre-eclampsia
Crude 1.0 1.17 (0.95 to 1.45) 1.45 (1.13 to 1.86)
Adjusted 1.0 1.21 (0.98 to 1.50) 1.74 (1.35 to 2.25)
Preterm delivery
Crude 1.0 1.23 (1.02 to 1.47) 1.25 (1.00 to 1.56)
Adjusted 1.0 1.22 (1.02 to 1.47) 1.25 (1.00 to 1.56)
Perinatal mortality
Crude 1.0 1.48 (0.71 to 3.08) 1.14 (0.44 to 2.98)
Adjusted 1.0 1.47 (0.70 to 3.03) 1.08 (0.41 to 2.83)
Caesarean section
Crude 1.0 1.38 (1.19 to 1.60) 1.69 (1.40 to 2.04)
Adjusted 1.0 1.37 (1.18 to 1.60) 1.67 (1.38 to 2.03)
Neonatal overweight
Crude 1.0 1.17 (0.98 to 1.40) 1.35 (1.09 to 1.67)
Adjusted 1.0 1.19 (0.99 to 1.42) 1.36 (1.09 to 1.69)
Reference group: type 1 diabetic women with normal pre-pregnancy BMI.
*Adjusted for ethnicity, maternal age, height, parity, smoking ﬁrst trimester and chronic hypertension.
BMI, body mass index; LGA, large for gestational age; T1DM, type 1 diabetes.
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BMI. The Swedish MBR does not collect data on
maternal glycaemic control, duration of diabetes and
insulin regimens or data on diet and physical activity.
Data on socioeconomic factors are also very limited.
Consequently, the impact of socioeconomic factors, diet,
physical activity and level of control on the risk of
adverse outcome could not be assessed. It is plausible
that the achieved level of metabolic control differed
between normal weight, overweight and obese type 1
diabetic women. In a study on pregnancies complicated
by gestational diabetes, the fasting glucose levels were
signiﬁcantly higher in obese compared with overweight
and normal weight women.
14 However, results from the
HAPO study conﬁrm that maternal BMI and glycaemia
exert independent effects on the risk of adverse
pregnancy outcome.
2
In the present study, obese women with T1DM had
signiﬁcantly increased risks of major malformations and
PE as compared with normal weight women with T1DM.
This is in line with the ﬁnding of an interaction between
maternal diabetes and obesity on the risk of adverse
outcome in a mixed population of women with different
types of diabetes.
17 However, the increased risk of major
malformations in relation to BMI in the present analysis
should be interpreted with caution as maternal over-
weight and obesity rend ultrasound assessment of fetal
anatomy difﬁcult,
22 and we do not have data on the
number of induced abortions due to malformations.
Maternal hyperglycaemia in early pregnancy is a well-
known risk factor for major malformations and PE.
23
Obesity is associated with increased insulin resistance,
12
and one could speculate that women with obesity had
a poorer level of control in early pregnancy than women
with normal or slightly elevated BMI. In line with
previous studies, we found increased risks of PE and
major malformations in obese non-diabetic women.
561 0
In the present study, the risks of these complications
were also signiﬁcantly elevated in non-diabetic women
with overweight. Obesity is associated with decreased
insulin sensitivity, and already slightly elevated levels of
fasting glucose, within the upper normal range, are
associated with increased risk of PE in women without
diabetes.
24 In Sweden, there is no uniform screening for
gestational diabetes. It is possible that the increased
risk of PE and major malformations in overweight and
obese women in the reference group is partly due to
undetected cases of impaired glucose tolerance or dia-
betes. Interestingly, maternal pre-pregnancy BMI has
been demonstrated as a stronger predictor of major
malformations than severity of gestational diabetes.
25
In women with T1DM, the incidence of LGA was very
high in all weight classes and increased with greater BMI
category. However, the OR for an LGA outcome did not
differ signiﬁcantly between BMI categories, as opposed
to in non-diabetic women. This is in accordance with
ﬁndings in two recent studies.
26 27 On the contrary, the
risk of delivering a disproportionate, overweight LGA
infant (PI >90th percentile) was signiﬁcantly increased
in obese women within the type 1 diabetic cohort. In
accordance with the study by Ehrenberg, our ﬁndings
indicate that maternal overweight is an important risk
factor for LGA, but maternal diabetes has an even
greater impact.
28 A possible contributing factor to this
ﬁnding could also be the increasing prevalence of PE
with greater BMI category.
This study conﬁrms the observations in non-diabetic
pregnancies
2e5 that increasing maternal BMI is associ-
ated with increased risk of delivery by Caesarean section
also in women with T1DM. The increased incidence of
complications such as PE and LGA in these groups most
likely contributes to this ﬁnding.
The majority of perinatal deaths were stillbirths in all
BMI categories and in both women with and without
T1DM. The risk of perinatal mortality was independent
of BMI category within the type 1 diabetic cohort but
increased signiﬁcantly with higher BMI in the reference
group. This ﬁnding is in line with previous studies,
reporting increased risk of both stillbirth and neonatal
mortality in obese non-diabetic women even after
adjusting for maternal and perinatal risk factors.
7e9 The
lack of a signiﬁcantly increased risk of perinatal mortality
with increasing BMI category within the diabetes
cohort indicate that diabetes is a stronger risk factor for
perinatal mortality than maternal overweight/obesity.
In the present study, we found an increasing risk of
preterm delivery with greater BMI category, both in
women with and without T1DM. Results from some
earlier studies have shown an increased risk of preterm
delivery in obese non-diabetic women,
3 4 while others
have reported the opposite association.
25
It is hypothesised that the increased risk of pregnancy
complications in overweight and obese women is related
to increased maternal fat mass. In the present study, pre-
pregnancy BMI was used as a proxy for maternal fat mass
as there is a strong correlation (r
2¼0.86) between pre-
pregnancy BMI and maternal fat mass in women without
diabetes.
29 However, BMI does not provide information
on the localisation of fat mass. One suggested link
between high maternal pre-pregnancy BMI and
increased risk of adverse outcome pregnancy is a large
visceral fat mass. The visceral fat mass is associated with
increased insulin resistance, inﬂammation and lipotox-
icity with potential harmful effects on maternal vascular
and placental function and fetal development.
30 Other
pathophysiological mechanisms behind the increased
risk of adverse pregnancy outcome in overweight/obese
mothers are not clear but are most likely complex.
Genetic and socioeconomic factors, maternal diet and
physical activity are probable contributing factors.
In conclusion, this population-based study on more
than 3000 type 1 diabetic pregnancies demonstrates
a strong association between maternal pre-pregnancy
BMI and elevated risk of adverse pregnancy outcome.
T1DM in combination with overweight or obesity
constitutes a higher risk than either condition alone.
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with T1DM could hopefully reduce the risk of adverse
outcome.
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